I would agree; its amazing how they give numbers and quite often dont provide any details as well. SNTA mgt. has to take the bull by the horns now and surprise everyone with really good news. I thought the restructuring was done fairly well...I still would like to see them replace several more players ....those responsible for creating the clinical trial plans. Overall, I strongly believe once the new CEO is named (as long as he or she is a good one)....we will finally start the long overdue uptrend.